170837 ⎘
Detection or diagnosis of diseases; Immunology or allergic disorders Transplantation related diseases, e.g. graft versus host disease
Anti-CD74 immunoconjugates and methods of use
#302Methods and kits for screening transplant recipients and candidates
#303NEUTROKINE-ALPHA ANTIBODIES AND METHODS OF USE THEREOF
#304ASSESSMENT AND REDUCTION OF RISK OF GRAFT-VERSUS-HOST DISEASE
#305Diagnostic Assay
#306NEW BIOMARKER FOR MONITORING DEVELOPMENT OF DISEASES AND ASSESSING THE EFFICACY OF THERAPIES
#307Polypeptide Markers for the Early Recognition of the Rejection of Transplanted Kidneys
#308TISSUE REJECTION BIOMARKERS
#309METHOD FOR DETECTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE
#310GPIIIa gene
#311HMG1 antibody for treating inflammatory conditions
#312Tissue Rejection
#313Methods and compositions for diagnosing and monitoring transplant rejection
#314DETECTION OF ORGAN REJECTION
#315Method for reducing the risk of spontaneous abortion in a human female subject
#316Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
#317ASSAYS TO PREDICT AND MONITOR ANTIBODY MEDIATED REJECTION OF TRANSPLANTED ALLOGRAFTS
#318Screening methods for transfusion related acute lung injury (TRALI)
#319METHOD FOR DIAGNOSIS OF CHRONIC ALLOGRAFT REJECTION
#320Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
#321PREDICTIVE BIOMARKERS FOR CHRONIC ALLOGRAFT NEPHROPATHY
#322Method of assessing progress of kidney regeneration
#323ASSESSMENT OF CELLULAR COMPOSITION AND FRACTIONAL VIABILITY AND USES THEREOF
#324C4d/C4b standard for quantitative flow cytometry of humoral transplant rejection
#325Antagonists of HMG1 for treating inflammatory conditions
#326COMPOSITIONS, KITS AND METHODS FOR DETERMINING ETIOLOGY OF TRALI AND DETECTING PATIENTS AT RISK FOR THIS TRANSFUSION REACTION
#327STIMULATORY AUTO-ANTIBODIES TO THE PDGF RECEPTORS AS PATHOLOGY MARKER AND THERAPEUTIC TARGET
#328MULTIPLE ADMINISTRATIONS OF UMBILICUS DERIVED CELLS
#329SYSTEMS AND METHODS FOR CHARACTERIZING KIDNEY DISEASE
#330Graft-versus-host disease predicting marker and use thereof
#331Neutrokine-alpha antibodies and methods of use thereof
#332Gene Markers and Utilization of the Same
#333SPECIFIC REMOVAL OF ACTIVATED IMMUNE CELLS
#334Skeletal Site-Specific Characterization of Orofacial and Illiac Crest Human Bone Marrow Stromal Cells in Same Individuals
#335Methods of donor specific crossmatching
#336Methods and Compositions for Diagnosing Disease
#337Method of Detecting Kidney Dysfunction
#338Serum biomarkers for early detection of acute cellular rejection
#339Method for Monitoring the Immune Response and Predicting Clinical Outcomes in transplant recipients
#340ANTI-PRO87299 ANTIBODIES
#341PIF peptides biologic activities, site of action, and the antibody to detect PIF
#342Methods of treatment using antibodies to neutrokine-alpha
#343Gene Marker and Use Thereof
#344Anti-PRO87299 antibodies
#345Methods of detecting antibodies specific for denatured HLA antigens
#346METHOD, APPARATUS, AND COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER
#347Biomarker for cardiac transplant rejection
#348Cd4+ Cd25+ T-cells activated to a specific antigen
#349Method of detecting early immune activation
#350Therapeutic Strategy for Treating Autoimmune and Degenerative Diseases
#351ANTAGONIZING INTERLEUKIN-21 RECEPTOR ACTIVITY
#352Cytotrophoblast Stem Cell
#353Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
#354Markers of renal transplant rejection and renal damage
#355Methods of Using FOXP3 Levels to Predict the Outcome of Organs Undergoing Acute Rejection
#356Granulysin and uses thereof
#357Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
#358Biotinylated MHC complexes and their uses
#359Systems and methods for identifying organ transplant risk
#360Methods and reagents for detecting susceptibility to graft versus host disease or transplant related mortality
#361Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3
#362Assessment and reduction of risk of graft-versus-host disease
#363Systems and methods for characterizing kidney diseases
#364Blood group antigens of different types for diagnostic and therapeutic applications
#365Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof
#366Systems and methods for monitoring immune responses and predicting outcomes in transplant recipients
#367Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
#368Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
#369Isolated cd4+ t cells defined by cmrf-35
#370CD86 and CD80 receptor competition assays
#371PRO87299 polypeptides
#372Systems and methods for characterizing conditions and diseases associated with organ transplantation and organ health
#373COMPOSITIONS COMPRISING ANTIBODIES TO HUMAN FGL2
#374Rapid serum sugar biomarker assay of rheumatoid arthritis
#375Method for diagnosis of chronic allograft rejection
#376Methods and compositions for diagnosing and monitoring transplant rejection
#377Methods and kits for drug screening and toxicity testing using promoter-reporter cells derived from embryonic stem cells
#378Tissue rejection
#379Molecular dissection of cellular responses to alloantigen or autoantigen in graft rejection and autoimmune disease
#380Antagonists of HMG1 for treating inflammatory conditions
#381Prevention and treatment for GVHD
#382Immunologic activity measures for t helper on-associated conditions
#383Methods for treating inflammatory disorders using regulators of microvessel dilations
#384Methods of diagnosing sepsis by measuring HMG1
#385Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
#386Methods of treatment using antibodies to Neutrokine-alpha
#387Methods of Treatment Using Antibodies to Neutrokine-alpha
#388Treating autoimmune diseases with humanized anti-CD401 antibodies
#389Method and markers for the diagnosis of Graft versus Host Disease (GvHD)
#390Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration
#391Method for the early detection of breast cancer, lung cancer, pancreatic cancer and colon polyps, growths and cancers as well as other gastrointestinal disease conditions and the preoperative and postoperative monitoring of transplanted organs from the donor and in the recipient and their associated conditions related and unrelated to the organ transplantation
#392Methods and compositions for diagnosing and monitoring transplant rejection
#393Antagonizing interleukin-21 receptor activity
#394System and methods for the management and treatment of vascular graft disease
#395Anti-PRO87299 antibodies
#396Compositions and methods for modulating immune response
#397Methods of donor specific crossmatching
#398Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
#399Methods of treating NFAT-related disorders
#400Use of tyrosine kinase inhibitors for treating autoimmune diseases
#401Compositions comprising antibodies to human FgI2
#402Systems and methods for characterizing kidney diseases
#403Methods and materials for the inhibition of transplant rejection
#404Identification and quantification of organ-specific proteins derived from human allogeneic cells using proteomics
#405Biomarker for the prediction of primary non function of a liver graft